CONMED CNMD Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from CONMED’s reported figures.
Based on trailing twelve months.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's return on equity?
- CONMED (CNMD) reported return on equity of 5.5% in Q1 2026.
- How has CONMED's return on equity changed year-over-year?
- CONMED's return on equity decreased by 57.6% year-over-year, from 13% to 5.5%.
- What is the long-term trend for CONMED's return on equity?
- Over 4 years (2020 to 2025), CONMED's return on equity has grown at a 36.9% compound annual growth rate (CAGR), from 1.3% to 4.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.